Translating Muscle <scp>RNAseq</scp> Into the Clinic for the Diagnosis of Muscle Diseases

We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2025-05-25
DOI
https://doi.org/10.1002/acn3.70078
Citations
4
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases

C. Jimenez‐Mallebrera, Montse Olivé, Lidia González‐Quereda, Velina Nedkova et al.
4 citations
Annals of Clinical and Translational Neurology
RNA Research and Splicing
3.22
article

Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases

C. Jimenez‐Mallebrera, Montse Olivé, Lidia González‐Quereda, Velina Nedkova, Benjamín Rodríguez‐Santiago, Solange Kapetanovic, Arístides López‐Márquez, Cristina Domínguez‐González, C. Ortez, Berta Estévez‐Arias, A. Nascimento, Itxaso Martì, Alba Segarra‐Casas, Eduard Gallardo, Laura González, Raúl Juntas‐Morales, Laura Llansó, Roberto Fernández‐Torrón, Daniel Natera‐de Benito, Cristina Jou, Jordi Surrallés, P. Gallano, María José Gómez-Rodríguez, Aurelio Hernández‐Laín, Adolfo López‐de Munain
article en
4 citations

Abstract

We demonstrate the utility of RNAseq in identifying causative variants in muscle diseases. Evaluation of four aberrant splicing tools allowed efficient identification of most pathogenic splicing events, obtaining a manageable number of candidate events for manual inspection, demonstrating feasibility for translation into a clinical setting. We also show how the integration of omic technologies reduces the turnaround time to identify causative variants.

Annals of Clinical and Translational NeurologyVol. 12(7)
Universitat Autònoma de Barcelona (ES), Hospital Sant Joan de Déu Barcelona (ES), Universidad de Deusto (ES), University of the Basque Country (ES), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Institut d'Investigació Biomédica de Bellvitge (ES), BioCruces Health research Institute (ES), Hospital de Basurto (ES), Biogipuzkoa Health Research Institute (ES), Hospital Universitario 12 De Octubre (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Hospital Universitario HM Madrid (ES), ERN GUARD-Heart (NL), Onkologikoa (ES), Institut de Recerca Sant Joan de Déu, Universitat de Barcelona (ES)
European Commission, Generalitat de Catalunya, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III
Openalex Percentile: Top 8%
RNA Research and Splicing
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.